Ceftem is an orally active cephalosporin antibiotic with broad-spectrum bactericidal activity against a wide range of Gram-positive and Gram-negative bacteria. It is widely used in the treatment of acute bacterial infections affecting the upper and lower respiratory tract, including otitis media and bronchitis, particularly in cases where resistance to commonly used antibiotics is suspected. Ceftem is also indicated for urinary tract infections such as cystitis, cystourethritis, and pyelonephritis caused by susceptible organisms. Its proven clinical efficacy against common pathogens, including Streptococcus pneumoniae, Haemophilus influenzae, Escherichia coli, and Klebsiella species, makes it a reliable choice in antibacterial therapy. Ceftem remains highly stable in the presence of beta-lactamase enzymes, supporting effective infection control and improved therapeutic outcomes.